These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
636 related articles for article (PubMed ID: 35604438)
1. Rescuing humanity by antimicrobial peptides against colistin-resistant bacteria. Moghadam MT; Mojtahedi A; Moghaddam MM; Fasihi-Ramandi M; Mirnejad R Appl Microbiol Biotechnol; 2022 Jun; 106(11):3879-3893. PubMed ID: 35604438 [TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles. van der Weide H; Vermeulen-de Jongh DMC; van der Meijden A; Boers SA; Kreft D; Ten Kate MT; Falciani C; Pini A; Strandh M; Bakker-Woudenberg IAJM; Hays JP; Goessens WHF Int J Antimicrob Agents; 2019 Aug; 54(2):159-166. PubMed ID: 31173867 [TBL] [Abstract][Full Text] [Related]
3. Susceptibility of Colistin-Resistant, Gram-Negative Bacteria to Antimicrobial Peptides and Ceragenins. Hashemi MM; Rovig J; Weber S; Hilton B; Forouzan MM; Savage PB Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584137 [TBL] [Abstract][Full Text] [Related]
4. Antimicrobial peptides for combating drug-resistant bacterial infections. Xuan J; Feng W; Wang J; Wang R; Zhang B; Bo L; Chen ZS; Yang H; Sun L Drug Resist Updat; 2023 May; 68():100954. PubMed ID: 36905712 [TBL] [Abstract][Full Text] [Related]
6. Antimicrobial Peptides and Macromolecules for Combating Microbial Infections: From Agents to Interfaces. Yu L; Li K; Zhang J; Jin H; Saleem A; Song Q; Jia Q; Li P ACS Appl Bio Mater; 2022 Feb; 5(2):366-393. PubMed ID: 35072444 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii. Vila-Farres X; Garcia de la Maria C; López-Rojas R; Pachón J; Giralt E; Vila J Clin Microbiol Infect; 2012 Apr; 18(4):383-7. PubMed ID: 21672084 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial Peptide Exposure Selects for Resistant and Fit Stenotrophomonas maltophilia Mutants That Show Cross-Resistance to Antibiotics. Blanco P; Hjort K; Martínez JL; Andersson DI mSphere; 2020 Sep; 5(5):. PubMed ID: 32999081 [TBL] [Abstract][Full Text] [Related]
9. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance? Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762 [TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii. García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380 [TBL] [Abstract][Full Text] [Related]
12. Antimicrobial Peptides Therapy: An Emerging Alternative for Treating Drug-Resistant Bacteria. Mba IE; Nweze EI Yale J Biol Med; 2022 Dec; 95(4):445-463. PubMed ID: 36568838 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial peptides, conventional antibiotics, and their synergistic utility for the treatment of drug-resistant infections. Zhu Y; Hao W; Wang X; Ouyang J; Deng X; Yu H; Wang Y Med Res Rev; 2022 Jul; 42(4):1377-1422. PubMed ID: 34984699 [TBL] [Abstract][Full Text] [Related]
14. Current synthetic chemistry towards cyclic antimicrobial peptides. He T; Qu R; Zhang J J Pept Sci; 2022 Jun; 28(6):e3387. PubMed ID: 34931393 [TBL] [Abstract][Full Text] [Related]
15. An overview of antimicrobial peptides and the latest advances in their development. Sierra JM; Fusté E; Rabanal F; Vinuesa T; Viñas M Expert Opin Biol Ther; 2017 Jun; 17(6):663-676. PubMed ID: 28368216 [TBL] [Abstract][Full Text] [Related]
16. Cathelicidin Antimicrobial Peptides with Reduced Activation of Toll-Like Receptor Signaling Have Potent Bactericidal Activity against Colistin-Resistant Bacteria. Kao C; Lin X; Yi G; Zhang Y; Rowe-Magnus DA; Bush K mBio; 2016 Sep; 7(5):. PubMed ID: 27651360 [TBL] [Abstract][Full Text] [Related]
17. No country for old antibiotics! Antimicrobial peptides (AMPs) as next-generation treatment for skin and soft tissue infection. Răileanu M; Borlan R; Campu A; Janosi L; Turcu I; Focsan M; Bacalum M Int J Pharm; 2023 Jul; 642():123169. PubMed ID: 37356506 [TBL] [Abstract][Full Text] [Related]